These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29633861)

  • 1. Approaches to measure protein binding of enzymatically unstable compounds in plasma.
    Ye Z; Gao H
    Bioanalysis; 2018 Apr; 10(7):451-459. PubMed ID: 29633861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor.
    Eng H; Niosi M; McDonald TS; Wolford A; Chen Y; Simila ST; Bauman JN; Warmus J; Kalgutkar AS
    Xenobiotica; 2010 Jun; 40(6):369-80. PubMed ID: 20297923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds.
    Wang C; Williams NS
    J Pharm Biomed Anal; 2013 Mar; 75():112-7. PubMed ID: 23312388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pH on plasma protein binding in equilibrium dialysis.
    Kochansky CJ; McMasters DR; Lu P; Koeplinger KA; Kerr HH; Shou M; Korzekwa KR
    Mol Pharm; 2008; 5(3):438-48. PubMed ID: 18345638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the accuracy of unbound fraction measurement of drug-protein binding by preconditioning the RED membrane inserts.
    Ye Z; Chen Q
    Bioanalysis; 2020 Dec; 12(23):1699-1708. PubMed ID: 33179537
    [No Abstract]   [Full Text] [Related]  

  • 7. Development and validation of a higher-throughput equilibrium dialysis assay for plasma protein binding.
    van Liempd S; Morrison D; Sysmans L; Nelis P; Mortishire-Smith R
    J Lab Autom; 2011 Feb; 16(1):56-67. PubMed ID: 21609686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Experimental Variables on the Protein Binding of Tigecycline in Human Plasma as Determined by Ultrafiltration.
    Dorn C; Kratzer A; Liebchen U; Schleibinger M; Murschhauser A; Schlossmann J; Kees F; Simon P; Kees MG
    J Pharm Sci; 2018 Feb; 107(2):739-744. PubMed ID: 28927988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical and Experimental Validation of Flux Dialysis Method: An Improved Approach to Measure Unbound Fraction for Compounds with High Protein Binding and Other Challenging Properties.
    Kalvass JC; Phipps C; Jenkins GJ; Stuart P; Zhang X; Heinle L; Nijsen MJMA; Fischer V
    Drug Metab Dispos; 2018 Apr; 46(4):458-469. PubMed ID: 29437872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying Two Orthogonal Methods to Assess Accuracy of Plasma Protein Binding Measurements for Highly Bound Compounds.
    Ryu S; Riccardi K; Patel R; Zueva L; Burchett W; Di L
    J Pharm Sci; 2019 Nov; 108(11):3745-3749. PubMed ID: 31419399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A kinetic method for the determination of plasma protein binding of compounds unstable in plasma: Specific application to enalapril.
    Wenlock MC; Barton P; Austin RP
    J Pharm Biomed Anal; 2011 Jun; 55(3):385-90. PubMed ID: 21371844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Counter Equilibrium Dialysis (CED) to Increase Confidence in the Measurement of Free Fraction for Challenging Compounds.
    Huang J; Yan Z; Cai J
    J Pharm Sci; 2023 Sep; 112(9):2561-2569. PubMed ID: 37187260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma protein binding monitoring of therapeutic drugs in patients using single set of hollow fiber centrifugal ultrafiltration.
    Wang X; Li C; Du C; Gao JL; Zhao KX; Shi R; Jiang Y
    Bioanalysis; 2017 Apr; 9(7):579-592. PubMed ID: 28355126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of compound binding to plasma proteins.
    Dow N
    Curr Protoc Pharmacol; 2006 Oct; Chapter 7():Unit7.5. PubMed ID: 22294178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rat in vitro plasma-binding percentage determination of sinomenine hydrochloride by using microdialysis method and ultrafiltration].
    Zhang Y; Zhou L
    Zhongguo Zhong Yao Za Zhi; 2010 Oct; 35(19):2616-9. PubMed ID: 21174777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-binding characteristics of voriconazole determined by high-throughput equilibrium dialysis.
    Vanstraelen K; Wauters J; De Loor H; Vercammen I; Annaert P; Lagrou K; Spriet I
    J Pharm Sci; 2014 Aug; 103(8):2565-70. PubMed ID: 24961809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein binding in antiretroviral therapies.
    Boffito M; Back DJ; Blaschke TF; Rowland M; Bertz RJ; Gerber JG; Miller V
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):825-35. PubMed ID: 14585213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding.
    Waters NJ; Jones R; Williams G; Sohal B
    J Pharm Sci; 2008 Oct; 97(10):4586-95. PubMed ID: 18300299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategy for Determining the Free Fraction of Labile Covalent Modulators in Plasma Using Equilibrium Dialysis.
    Leung C; Kenny JR; Hop CECA; Yan Z
    J Pharm Sci; 2020 Oct; 109(10):3181-3189. PubMed ID: 32663597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Industry Perspective on Contemporary Protein-Binding Methodologies: Considerations for Regulatory Drug-Drug Interaction and Related Guidelines on Highly Bound Drugs.
    Di L; Breen C; Chambers R; Eckley ST; Fricke R; Ghosh A; Harradine P; Kalvass JC; Ho S; Lee CA; Marathe P; Perkins EJ; Qian M; Tse S; Yan Z; Zamek-Gliszczynski MJ
    J Pharm Sci; 2017 Dec; 106(12):3442-3452. PubMed ID: 28927987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.